Latest AI and machine learning research in nuclear medicine for healthcare professionals.
Impulse control disorders (ICD) in Parkinson’s disease (PD) patients mainly occur as adverse effects of dopamine replacement therapy. Despite several known risk factors associated with ICD development, this cannot yet be accurately predicted at PD diagnosis. We aimed to investigate the predictability of incident ICD by baseline measures of demographic, clinical, dopamine transporter single photon ...
Positron Emission Tomography (PET) myocardial perfusion imaging (MPI) is a powerful tool for predicting coronary artery disease (CAD). Coronary artery calcium (CAC) provides incremental risk stratification to PET-MPI and enhances diagnostic accuracy. We assessed additive value of CAC score, derived from PET/CT attenuation maps to stress TPD results using the novel 18F-flurpiridaz tracer in detecti...
Positron emission tomography (PET)/CT for myocardial perfusion imaging (MPI) provides multiple imaging biomarkers, often evaluated separately. We deve...
Precise quantification of myocardial blood flow (MBF) and flow reserve (MFR) in 18F-flurpiridaz PET significantly relies on motion correction (MC). Ho...
Alzheimer’s disease (AD), the most prevalent neurodegenerative disorder, is marked by the accumulation of amyloid-β (Aβ) plaques. Although cerebral Aβ...
Hepatic steatosis (HS) is a common cardiometabolic risk factor frequently present but under-diagnosed in patients with suspected or known coronary art...
The REgistry of Flow and Perfusion Imaging for Artificial INtelligEnce with PET (REFINE PET) was established to aggregate PET and associated computed ...
PSMA PET/CT imaging has been increasingly utilized in the management of patients with metastatic prostate cancer (mPCa). Imaging biomarkers derived fr...
Dynamic Positron Emission Tomography (PET) scans offer rich spatiotemporal data for detecting malignancies, but their high-dimensionality and noise po...
This study evaluates the capability of diffusion-based generative models to reconstruct diagnostic-quality renal cortical images from reduced-acquisit...
Coronary microvascular disease (CMVD) is an underdiagnosed but significant contributor to the burden of ischemic heart disease, characterized by angin...
Cardiac amyloidosis (CA) is an underdiagnosed infiltrative cardiomyopathy associated with poor outcomes if not detected early. Artificial intelligence...
Medical imaging is crucial for glioma management. Combined with MRI, amino acid PET may improve glioma diagnosis, biopsy targeting, and tumor delineat...
Alzheimer’s disease (AD) involves early molecular changes beyond amyloid-β (Aβ) and tau, that create heterogeneous disease biology, giving rise to var...
To determine if combining PET-derived beta-cell mass (BCM) estimates with MRI- based morphology metrics improves the prediction of beta-cell functiona...
The wide availability of labeled electrocardiogram (ECG) data has driven major advances in artificial intelligence (AI)-based detection of structural ...
The Brain Imaging and Neurophysiology Database (BIND) represents one of the largest multi-institutional, multimodal, clinical neuroimaging repositorie...
Quantitative PET underpins diagnosis and treatment monitoring in neurodegenerative disease, yet systematic biases between PET-MRI and PET-CT preclude ...
Differentiating malignant from inflammatory uptake on 18F-FDG PET/CT remains a major diagnostic challenge, as standardized uptake value (SUV) lacks sp...
Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by heterogeneous pathophysiological changes that begin years before symptoms em...